These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9407447

  • 1. Economic evaluation of benazepril in chronic renal insufficiency.
    van Hout BA, Simeon GP, McDonnell J, Mann JF.
    Kidney Int Suppl; 1997 Dec; 63():S159-62. PubMed ID: 9407447
    [Abstract] [Full Text] [Related]

  • 2. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P.
    N Engl J Med; 1996 Apr 11; 334(15):939-45. PubMed ID: 8596594
    [Abstract] [Full Text] [Related]

  • 3. Long-term progression of chronic renal insufficiency in the AIPRI Extension Study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Locatelli F, Carbarns IR, Maschio G, Mann JF, Ponticelli C, Ritz E, Alberti D, Motolese M, Janin G, Zucchelli P.
    Kidney Int Suppl; 1997 Dec 11; 63():S63-6. PubMed ID: 9407424
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.
    Costa-Scharplatz M, van Asselt AD, Bachmann LM, Kessels AG, Severens JL.
    Pharmacogenet Genomics; 2007 May 11; 17(5):359-68. PubMed ID: 17429318
    [Abstract] [Full Text] [Related]

  • 5. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
    J Hypertens; 2000 Jan 11; 18(1):89-95. PubMed ID: 10678548
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
    Hogan TJ, Elliott WJ, Seto AH, Bakris GL.
    Pharmacoeconomics; 2002 Jan 11; 20(1):37-47. PubMed ID: 11817991
    [Abstract] [Full Text] [Related]

  • 7. [Reduced progression, increased mortality in chronic renal disease after treatment with the angiotensin-converting enzyme inhibitor benazepril].
    Pedersen EB.
    Ugeskr Laeger; 1996 Oct 07; 158(41):5798-9. PubMed ID: 8928272
    [No Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ.
    Pharmacogenet Genomics; 2009 Sep 07; 19(9):695-703. PubMed ID: 19696696
    [Abstract] [Full Text] [Related]

  • 9. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
    Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S.
    CMAJ; 2000 Jan 25; 162(2):195-8. PubMed ID: 10674051
    [Abstract] [Full Text] [Related]

  • 10. Benazepril: a new ACE inhibitor.
    Bell J.
    ANNA J; 1993 Apr 25; 20(2):187-8. PubMed ID: 8512378
    [Abstract] [Full Text] [Related]

  • 11. Economic evaluation of sevelamer in patients with end-stage renal disease.
    Manns B, Klarenbach S, Lee H, Culleton B, Shrive F, Tonelli M.
    Nephrol Dial Transplant; 2007 Oct 25; 22(10):2867-78. PubMed ID: 17595182
    [Abstract] [Full Text] [Related]

  • 12. [Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L?].
    Zhang GH, Hou FF, Zhang X, Liu QF.
    Zhonghua Nei Ke Za Zhi; 2005 Aug 25; 44(8):592-6. PubMed ID: 16194413
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, Geng RW.
    N Engl J Med; 2006 Jan 12; 354(2):131-40. PubMed ID: 16407508
    [Abstract] [Full Text] [Related]

  • 14. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model.
    Campbell HM, Boardman KD, Dodd MA, Raisch DW.
    Ann Pharmacother; 2007 Jul 12; 41(7):1101-10. PubMed ID: 17609233
    [Abstract] [Full Text] [Related]

  • 15. Treatment of IgA nephropathy with angiotensin converting enzyme inhibitors: design of a prospective randomized multicenter trial.
    Coppo R, Chiesa M, Peruzzi L, Amore A.
    J Nephrol; 2001 Jul 12; 14(6):447-52. PubMed ID: 11783600
    [Abstract] [Full Text] [Related]

  • 16. Effect of benazepril in chronic renal insufficiency.
    Curren CG.
    N Engl J Med; 1996 Aug 22; 335(8):597; author reply 597. PubMed ID: 8684418
    [No Abstract] [Full Text] [Related]

  • 17. Effect of benazepril in chronic renal insufficiency.
    Apperloo AJ, Rensma PL.
    N Engl J Med; 1996 Aug 22; 335(8):596-7; author reply 597. PubMed ID: 8684417
    [No Abstract] [Full Text] [Related]

  • 18. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency.
    Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, Jiang JP.
    J Am Soc Nephrol; 2007 Jun 22; 18(6):1889-98. PubMed ID: 17494885
    [Abstract] [Full Text] [Related]

  • 19. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
    Kutyrina IM, Lifshits NL, Rogov VA, Kamyshova ES, Shvetsov MIu, Okonova EB, Androsova SO, Martynov SA, Miroshnichenko NG, Gerasimenko OI.
    Ter Arkh; 2002 Jun 22; 74(6):34-9. PubMed ID: 12136480
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the clinical efficacy of benazepril in the treatment of chronic renal insufficiency in cats.
    Mizutani H, Koyama H, Watanabe T, Kitagawa H, Nakano M, Kajiwara K, King JN.
    J Vet Intern Med; 2006 Jun 22; 20(5):1074-9. PubMed ID: 17063698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.